137 related articles for article (PubMed ID: 38668861)
1. Biotransformation and toxicokinetics of 2-phenoxyethanol after oral exposure in humans: a volunteer study.
Eckert E; Jäger T; Hiller J; Leibold E; Bader M; Göen T
Arch Toxicol; 2024 Jun; 98(6):1771-1780. PubMed ID: 38668861
[TBL] [Abstract][Full Text] [Related]
2. A specific and sensitive GC-MS/MS method for the quantitative determination of 2-phenoxyethanol and selected metabolites in human blood and urine.
Jäger T; Eckert E; Leibold E; Bader M
J Anal Toxicol; 2024 Apr; ():. PubMed ID: 38662393
[TBL] [Abstract][Full Text] [Related]
3. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
Troutman JA; Rick DL; Stuard SB; Fisher J; Bartels MJ
Regul Toxicol Pharmacol; 2015 Nov; 73(2):530-43. PubMed ID: 26188115
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tissue and urine concentrations of 2-phenoxyethanol and its metabolite 2-phenoxyacetic acid in rat and human after oral and dermal exposures via GastroPlus
Zhang F; LeBaron MJ; Marty MS
SAR QSAR Environ Res; 2022 May; 33(5):323-339. PubMed ID: 35301938
[TBL] [Abstract][Full Text] [Related]
5. Reliable determination of the main metabolites of 2-phenoxyethanol in human blood and urine using LC-MS/MS analysis.
Jäger T; Eckert E; Leibold E; Bader M
Anal Methods; 2022 Nov; 14(43):4408-4417. PubMed ID: 36300334
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats.
Kwon M; Park JB; Kwon M; Song J; Yeo CS; Bae SH
Arch Toxicol; 2021 Jun; 95(6):2019-2036. PubMed ID: 33844041
[TBL] [Abstract][Full Text] [Related]
7. Toxicokinetics of a urinary metabolite of tebuconazole following controlled oral and dermal administration in human volunteers.
Oerlemans A; Verscheijden LFM; Mol JGJ; Vermeulen RCH; Westerhout J; Roeleveld N; Russel FGM; Scheepers PTJ
Arch Toxicol; 2019 Sep; 93(9):2545-2553. PubMed ID: 31359083
[TBL] [Abstract][Full Text] [Related]
8. Human metabolism and excretion kinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) after oral and dermal administration.
Pluym N; Roegner N; Peschel O; Leibold E; Scherer G; Scherer M
Arch Toxicol; 2023 Sep; 97(9):2419-2428. PubMed ID: 37392209
[TBL] [Abstract][Full Text] [Related]
9. Development of a urinary biomarker for exposure to the organophosphate propetamphos: data from an oral and dermal human volunteer study.
Garfitt SJ; Jones K; Mason HJ; Cocker J
Biomarkers; 2002; 7(2):113-22. PubMed ID: 12101631
[TBL] [Abstract][Full Text] [Related]
10. Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data.
Khmiri I; Côté J; Mantha M; Khemiri R; Lacroix M; Gely C; Toutain PL; Picard-Hagen N; Gayrard V; Bouchard M
Environ Int; 2020 May; 138():105644. PubMed ID: 32179324
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation and toxicokinetics of musk xylene in humans.
Riedel J; Dekant W
Toxicol Appl Pharmacol; 1999 Jun; 157(2):145-55. PubMed ID: 10366547
[TBL] [Abstract][Full Text] [Related]
12. Human metabolism and urinary excretion kinetics of the UV filter Uvinul A plus® after a single oral or dermal dosage.
Stoeckelhuber M; Scherer M; Peschel O; Leibold E; Bracher F; Scherer G; Pluym N
Int J Hyg Environ Health; 2020 Jun; 227():113509. PubMed ID: 32174481
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and metabolism of 14C/13C-labeled ortho-phenylphenol formation following dermal application to human volunteers.
Timchalk C; Selim S; Sangha G; Bartels MJ
Hum Exp Toxicol; 1998 Aug; 17(8):411-7. PubMed ID: 9756132
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics of urinary 2-ethylhexyl salicylate and its metabolite 2-ethyl-hydroxyhexyl salicylate in humans after simulating real-life dermal sunscreen exposure.
Hiller J; Klotz K; Meyer S; Uter W; Hof K; Greiner A; Göen T; Drexler H
Arch Toxicol; 2019 Sep; 93(9):2565-2574. PubMed ID: 31435713
[TBL] [Abstract][Full Text] [Related]
15. Additional oxidized and alkyl chain breakdown metabolites of the plasticizer DINCH in urine after oral dosage to human volunteers.
Schütze A; Otter R; Modick H; Langsch A; Brüning T; Koch HM
Arch Toxicol; 2017 Jan; 91(1):179-188. PubMed ID: 26976210
[TBL] [Abstract][Full Text] [Related]
16. Human metabolism and excretion kinetics of the fragrance 7-hydroxycitronellal after a single oral or dermal dosage.
Stoeckelhuber M; Krnac D; Pluym N; Scherer M; Peschel O; Leibold E; Scherer G
Int J Hyg Environ Health; 2018 Mar; 221(2):239-245. PubMed ID: 29108680
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and elimination of methyl, iso- and n-butyl paraben in human urine after single oral dosage.
Moos RK; Angerer J; Dierkes G; Brüning T; Koch HM
Arch Toxicol; 2016 Nov; 90(11):2699-2709. PubMed ID: 26608183
[TBL] [Abstract][Full Text] [Related]
18. Toxicokinetics of methyl tert-butyl ether and its metabolites in humans after oral exposure.
Amberg A; Rosner E; Dekant W
Toxicol Sci; 2001 May; 61(1):62-7. PubMed ID: 11294975
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics of homosalate in humans after dermal application: applicability of oral-route data for exposure assessment by human biomonitoring.
Ebert KE; Griem P; Weiss T; Brüning T; Hayen H; Koch HM; Bury D
Arch Toxicol; 2024 May; 98(5):1383-1398. PubMed ID: 38485782
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation and toxicokinetics of the insect repellent IR3535® in male and female human subjects after dermal exposure.
Broschard TH; Bohlmann AM; Konietzny S; Schauer UM; Dekant W
Toxicol Lett; 2013 Apr; 218(3):246-52. PubMed ID: 23402938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
